Results of Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue in 22 Patients With Refractory or Recurrent Primary CNS Lymphoma or Intraocular Lymphoma PURPOSE: Two phase II studies were ...
In this video, Lori Muffly, MD, MS, discussed a presentation from the Society of Hematologic Oncology Annual Meeting about the how the use of hyper-CVAD for acute lymphoblastic leukemia has evolved ...
Randomized Trial of Bone Marrow Versus Lenograstim-Primed Blood Cell Allogeneic Transplantation in Patients With Early-Stage Leukemia: A Report From the Société Française de Greffe de Moelle PURPOSE: ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio SAN DIEGO — The addition of nelarabine to ...
Forty patients with T-ALL/LL were enrolled with a median age of 38 years (19–78 years). Twenty-three patients (58%) had T-ALL and 17 (43%) had LL. The performance status was ⩽2 in 36/40 (90%) patients ...
Patients with testicular cancer had fewer venous access-related complications and overall thrombotic events when first-line chemotherapy was delivered via peripheral intravenous access compared with ...
TCT 241: Clinical Characteristics and Outcomes of Impella-Supported High-Risk PCI in Patients Turned Down for Coronary Artery Bypass Graft Surgery: Insights from the cVAD PROTECT III Study Receive the ...
Still, adding more Impella pumps is a big part of Abiomed's bottom line. The company booked $32.2 million in revenue during its fiscal 2012 third quarter, up 18% from the same period the previous year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback